Veer Bhavnagri - Mar 14, 2023 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
General Counsel
Signature
/s/Veer Bhavnagri
Stock symbol
ALLO
Transactions as of
Mar 14, 2023
Transactions value $
-$133,971
Form type
4
Date filed
3/16/2023, 04:46 PM
Previous filing
Feb 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Tax liability -$134 K -23.6 K -4.08% $5.67 556 K Mar 14, 2023 Direct F1, F2

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2 Includes 2,000 shares of the Issuer's common stock acquired by the reporting person on March 15, 2023 pursuant to an employee stock purchase program.